{
    "2020-10-25": [
        [
            {
                "time": "2023-10-01",
                "original_text": "半壁江山！中国新药许可交易数量激增，创新药企“十字路口”何去何从？",
                "features": {
                    "keywords": [
                        "中国新药",
                        "许可交易",
                        "创新药企",
                        "激增"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "热门融资标的股票分析",
                "features": {
                    "keywords": [
                        "热门融资",
                        "标的股票",
                        "分析"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "投资"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}